Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001213900-21-058780
Filing Date
2021-11-12
Accepted
2021-11-12 17:14:31
Documents
3

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS SUPPLEMENT ea150462-424b3_jaspertherap.htm 424B3 2055705
2 GRAPHIC image424b3_001.jpg GRAPHIC 3153
3 GRAPHIC image424b3_002.jpg GRAPHIC 116694
  Complete submission text file 0001213900-21-058780.txt   2222142
Mailing Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065
Business Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065 6505491400
Jasper Therapeutics, Inc. (Filer) CIK: 0001788028 (see all company filings)

EIN.: 842984849 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-260306 | Film No.: 211404838
SIC: 2836 Biological Products, (No Diagnostic Substances)